시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 아릴 탄화수소 수용체 시장 보고서(2025년)
Aryl Hydrocarbon Receptor Global Market Report 2025
상품코드 : 1815878
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

아릴 탄화수소 수용체 시장 규모는 앞으로 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 7.5%를 나타낼 것으로 예측되고 66억 3,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 정밀의학에 대한 투자 증가, 면역요법 수요 증가, 환경 건강에 대한 관심 증대, 염증성 질환 적용 확대, 신약 개발 진전 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 표적 암 치료 기술 발전, 정밀의학 접근법 도입, 독성학 연구 진전, 신약 개발 분야 인공지능(AI) 활용 확대, 자가면역질환 치료 기술 발전 등이 있습니다.

향후 5년간 7.5% 성장률 전망은 해당 시장 이전 추정치 대비 0.4% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향에 기인합니다. 관세 장벽은 스위스 및 프랑스에서 조달되는 아릴 탄화수소 수용체 표적 화합물 및 분석 키트의 비용을 증가시켜 미국 면역학 연구를 저해할 것으로 예상되며, 이로 인해 자가면역질환 연구가 지연되고 면역치료제 개발 비용이 상승할 것입니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.

자가면역 질환 및 만성 질환의 증가는 향후 몇 년간 아릴 탄화수소 수용체(AHR) 시장 성장을 주도할 것으로 예상됩니다. 자가면역 질환 및 만성 질환은 면역 체계가 오작동하거나 건강 문제가 지속되는 장기적 장애입니다. 이러한 질환의 증가는 유전적 요인, 환경적 영향, 생활 방식 변화, 장내 균형 불균형, 진단 능력 향상 등과 연관되어 있습니다. AHR은 T세포 분화 및 면역 세포 기능에 영향을 미쳐 자가면역 질환 및 만성 질환에 대한 치료적 이점을 제공함으로써 면역 반응과 염증을 조절할 잠재력을 지닙니다. 예를 들어, 2023년 7월 스코틀랜드 공중보건국은 2022년 다발성 경화증(MS) 신규 진단 사례가 전년 대비 87.2% 증가했으며(전년 증가율 85.7%), 491건의 신규 사례가 기록되어 총 6,359건에 달했다고 보고했습니다. 결과적으로 자가면역 질환 및 만성 질환의 증가는 AHR 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

The aryl hydrocarbon receptor is a protein that binds to environmental pollutants, such as dioxins, and regulates gene expression related to immune and inflammatory responses. It is used to modulate various biological processes, including the treatment of autoimmune and inflammatory conditions such as psoriasis, by selectively activating or inhibiting the receptor.

Key types of aryl hydrocarbon receptors include CB-993113, CDR-914K058, cinnabarinic acid, and others. CB-993113 is a small molecule inhibitor that targets the CBP/p300 bromodomain and is being studied for its potential to treat cancer and other diseases by modulating gene expression. These receptors and related compounds are distributed through various channels, such as direct sales, online platforms, distributors, retail pharmacies, and wholesale suppliers. They are used in treating conditions such as hepatocellular carcinoma, multiple sclerosis, obesity, and osteoporosis, and are applied across industries such as pharmaceuticals, biotechnology, agriculture, environmental consultancy, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The aryl hydrocarbon receptor market research report is one of a series of new reports from The Business Research Company that provides aryl hydrocarbon receptor market statistics, including the aryl hydrocarbon receptor industry global market size, regional shares, competitors with the aryl hydrocarbon receptor market share, detailed aryl hydrocarbon receptor market segments, market trends, and opportunities, and any further data you may need to thrive in the aryl hydrocarbon receptor industry. This aryl hydrocarbon receptor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The aryl hydrocarbon receptor market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $4.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising awareness of environmental toxins, increasing research in oncology, a rise in autoimmune disease studies, growing interest in targeted therapies, and expanding applications in drug development.

The aryl hydrocarbon receptor market size is expected to see strong growth in the next few years. It will grow to $6.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing investment in precision medicine, a rise in demand for immunotherapy, an increasing focus on environmental health, a rise in applications for inflammatory diseases, and increasing advancements in drug discovery. Major trends in the forecast period include advancement in targeted cancer therapies, adoption of precision medicine approaches, advancement in toxicology research, adoption of AI in drug discovery, and advancement in autoimmune disease treatment.

The forecast of 7.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. immunology research by increasing the cost of aryl hydrocarbon receptor targeting compounds and assay kits sourced from Switzerland and France, thereby delaying autoimmune disease research and elevating immunotherapeutic development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in autoimmune diseases and chronic conditions is expected to drive the growth of the aryl hydrocarbon receptor (AHR) market in the coming years. Autoimmune diseases and chronic conditions are long-lasting disorders where the immune system malfunctions or health issues persist. The rise in these conditions is linked to factors such as genetics, environmental influences, lifestyle changes, gut imbalances, and improved diagnostic capabilities. AHR agonists have the potential to regulate immune responses and inflammation, offering therapeutic benefits for autoimmune diseases and chronic conditions by influencing T-cell differentiation and immune cell function. For example, in July 2023, Public Health Scotland reported that newly diagnosed cases of multiple sclerosis (MS) in 2022 increased by 87.2%, compared to 85.7% the previous year, with 491 new cases recorded, bringing the total to 6,359. As a result, the rise in autoimmune diseases and chronic conditions is propelling the growth of the AHR agonist market.

Companies in the AHR market are focusing on developing advanced treatments, such as topical medications that target specific inflammatory pathways. These treatments offer potential solutions for autoimmune diseases such as psoriasis, multiple sclerosis, and other chronic inflammatory conditions while minimizing systemic side effects. Topical medications are applied directly to the skin or mucous membranes to treat localized conditions or symptoms. For example, in May 2022, Dermavant Sciences, a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for VTAMA (tapinarof) cream, 1%. This non-steroidal treatment option provides a unique mechanism of action through selective AHR modulation. Designed for once-daily application, VTAMA has shown a favorable safety profile with minimal systemic absorption, setting it apart from traditional therapies.

In September 2024, Organon & Co., a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for approximately $1.2 billion. This acquisition allows Organon to strengthen its dermatology portfolio by incorporating Dermavant's innovative dermatologic therapy, VTAMA (tapinarof) cream, 1%. Dermavant Sciences Ltd. specializes in developing AHR agonist-based therapies for dermatological conditions.

Major players in the aryl hydrocarbon receptor market are Bayer AG, Eli Lilly and Company, Organon & Co., Sigma-Aldrich Corporation, Bio-Techne Corporation, Abcam plc, R&D Systems Inc., Dermavant Sciences Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Tocris Bioscience, Ikena Oncology Inc., MedChemExpress LLC, Hercules Pharmaceuticals BV, Active Biotech AB, AnTolRx Inc., Aqilion AB, Azora Therapeutics Australia Pty Ltd, Sol-Gel Technologies Ltd., and Actavalon Inc.

North America was the largest region in the aryl hydrocarbon receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in aryl hydrocarbon receptor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aryl hydrocarbon receptor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aryl hydrocarbon receptor market consists of sales of synthetic AHR agonists, natural AHR agonists, AHR-targeted enzyme inhibitors, and pharmaceuticals targeting AHR pathways. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aryl Hydrocarbon Receptor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aryl hydrocarbon receptor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aryl hydrocarbon receptor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aryl hydrocarbon receptor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Aryl Hydrocarbon Receptor Market Characteristics

3. Aryl Hydrocarbon Receptor Market Trends And Strategies

4. Aryl Hydrocarbon Receptor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Aryl Hydrocarbon Receptor Growth Analysis And Strategic Analysis Framework

6. Aryl Hydrocarbon Receptor Market Segmentation

7. Aryl Hydrocarbon Receptor Market Regional And Country Analysis

8. Asia-Pacific Aryl Hydrocarbon Receptor Market

9. China Aryl Hydrocarbon Receptor Market

10. India Aryl Hydrocarbon Receptor Market

11. Japan Aryl Hydrocarbon Receptor Market

12. Australia Aryl Hydrocarbon Receptor Market

13. Indonesia Aryl Hydrocarbon Receptor Market

14. South Korea Aryl Hydrocarbon Receptor Market

15. Western Europe Aryl Hydrocarbon Receptor Market

16. UK Aryl Hydrocarbon Receptor Market

17. Germany Aryl Hydrocarbon Receptor Market

18. France Aryl Hydrocarbon Receptor Market

19. Italy Aryl Hydrocarbon Receptor Market

20. Spain Aryl Hydrocarbon Receptor Market

21. Eastern Europe Aryl Hydrocarbon Receptor Market

22. Russia Aryl Hydrocarbon Receptor Market

23. North America Aryl Hydrocarbon Receptor Market

24. USA Aryl Hydrocarbon Receptor Market

25. Canada Aryl Hydrocarbon Receptor Market

26. South America Aryl Hydrocarbon Receptor Market

27. Brazil Aryl Hydrocarbon Receptor Market

28. Middle East Aryl Hydrocarbon Receptor Market

29. Africa Aryl Hydrocarbon Receptor Market

30. Aryl Hydrocarbon Receptor Market Competitive Landscape And Company Profiles

31. Aryl Hydrocarbon Receptor Market Other Major And Innovative Companies

32. Global Aryl Hydrocarbon Receptor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aryl Hydrocarbon Receptor Market

34. Recent Developments In The Aryl Hydrocarbon Receptor Market

35. Aryl Hydrocarbon Receptor Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기